New York, NY, United States of America

Gad Lavie


 

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • New York, NY (US) (1991 - 2000)
  • Tenafly, NJ (US) (1996 - 2003)
  • Rehovot, IL (1998 - 2006)

Company Filing History:


Years Active: 1991-2006

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Gad Lavie: Innovator in Photodynamic Therapy and Anti-Cancer Research

Introduction

Gad Lavie is a prominent inventor based in New York, NY, known for his significant contributions to the fields of photodynamic therapy and anti-cancer research. With a total of 11 patents to his name, Lavie's work focuses on innovative methods to enhance the efficacy of cancer treatments while minimizing collateral damage to healthy tissues.

Latest Patents

Among his latest patents, one notable invention is a method for preventing or reducing collateral phototoxic damage to neighboring tissues during photodynamic therapy. This method regulates the localized phototoxicity of an effector photosensitizer molecule, effectively quenching its activity in surrounding tissues. Another significant patent involves helianthrone derivatives as anti-cancer agents. These compounds are designed to inhibit angiogenesis and can be utilized in the treatment of various tumors, even in the absence of light irradiation.

Career Highlights

Gad Lavie has worked with esteemed institutions such as New York University and Yeda Research and Development Company. His research has led to groundbreaking advancements in cancer treatment methodologies, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Lavie has collaborated with notable colleagues, including Daniel Meruelo and Yehuda Mazur. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Gad Lavie's contributions to photodynamic therapy and anti-cancer research highlight his role as a leading inventor in the medical innovation landscape. His patents reflect a commitment to advancing treatment options and improving the quality of care for patients facing cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…